Alpha Defensins May Be Protein Marker For Schizophrenia Risk
Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population. Diagnosis currently relies on subjective clinical interviews and the assessment of ambiguous symptoms, which frequently leads to delayed diagnosis and treatment. As such, biomarkers that would indicate schizophrenia risk or onset would be extremely useful.
A protein found in immune cells may be a reliable marker for schizophrenia risk, say researchers behind a new proteomics study.
Sabine Bahn and colleagues sought to find such a "protein fingerprint" in the blood (due to its accessibility).…